Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,607 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · derivative · entry 9 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,550 Underlying: Ordinary Shares · 6,607 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
SaleOrdinary Shares | 6,607 | $60.07 | $396,909.58 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · nonDerivative · entry 6 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,944 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.40. Full information regarding the number of shares sold at each separate price can be furnished to th Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionOrdinary Shares | 6,607 | $14.60 | $96,462.20 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · nonDerivative · entry 5 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,551 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,100 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · derivative · entry 10 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Underlying: Ordinary Shares · 2,100 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,100 | $60.12 | $126,246.33 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 7 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 06, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,100 | $18.11 | $38,020.50 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 6 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $17.30 | $0.00 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · derivative · entry 8 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,860 Underlying: Ordinary Shares · 300 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 05, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
SaleOrdinary Shares | 300 | $60.09 | $18,025.98 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · nonDerivative · entry 4 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,115 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 05, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionOrdinary Shares | 300 | $17.30 | $5,190.00 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · nonDerivative · entry 3 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,415 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 300 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · derivative · entry 8 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,157 Underlying: Ordinary Shares · 300 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
SaleOrdinary Shares | 300 | $60.10 | $18,030.99 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · nonDerivative · entry 4 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,944 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Cancel Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionOrdinary Shares | 300 | $14.60 | $4,380.00 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · nonDerivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,244 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · derivative · entry 9 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,100 Underlying: Ordinary Shares · 400 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 400 | $60.08 | $24,031.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Cancel Read SEC document |
| January 05, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 400 | $18.11 | $7,242.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $17.30 | $0.00 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · derivative · entry 7 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,160 Underlying: Ordinary Shares · 2,500 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 04, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
SaleOrdinary Shares | 2,500 | $60.01 | $150,017.50 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · nonDerivative · entry 2 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,115 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.05. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 04, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionOrdinary Shares | 2,500 | $17.30 | $43,250.00 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · nonDerivative · entry 1 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,615 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,543 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · derivative · entry 7 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,457 Underlying: Ordinary Shares · 2,543 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
SaleOrdinary Shares | 2,543 | $60.01 | $152,607.46 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,944 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.07. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Cancel Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:36 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionOrdinary Shares | 2,543 | $14.60 | $37,127.80 |
DisclosureSEC source: 0001127602-17-001308 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,487 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · derivative · entry 8 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,500 Underlying: Ordinary Shares · 7,500 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,500 | $60.01 | $150,022.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.04. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 5,000 | $58.83 | $294,126.00 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,140 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $58.80 to $59.01. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 23:28 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 7,500 | $18.11 | $135,787.50 |
DisclosureSEC source: 0001127602-17-001306 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,140 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 04, 2017 Filed Jan 6, 2017 22:43 UTC |
BREYER ROBERT ADirector
|
SaleOrdinary Shares | 4,000 | $60.00 | $240,000.00 |
DisclosureSEC source: 0001127602-17-001298 · form4.xml · nonDerivative · entry 1 BREYER ROBERT A · CIK 0001236441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,156 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:34 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $11.44 | $0.00 |
DisclosureSEC source: 0001127602-17-000745 · form4.xml · derivative · entry 3 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Ordinary Shares · 1,500 shares Expires 2018-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:34 UTC |
MITCHELL PAUL JDirector
|
SaleOrdinary Shares | 1,500 | $55.40 | $83,100.00 |
DisclosureSEC source: 0001127602-17-000745 · form4.xml · nonDerivative · entry 2 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:34 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionOrdinary Shares | 1,500 | $11.44 | $17,160.00 |
DisclosureSEC source: 0001127602-17-000745 · form4.xml · nonDerivative · entry 1 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:26 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 250 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001127602-17-000737 · form4.xml · derivative · entry 5 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Underlying: Ordinary Shares · 250 shares Expires 2017-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:26 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,250 | $0.00 Strike: $15.95 | $0.00 |
DisclosureSEC source: 0001127602-17-000737 · form4.xml · derivative · entry 4 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,250 Underlying: Ordinary Shares · 2,250 shares Expires 2017-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:26 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
SaleOrdinary Shares | 2,500 | $55.40 | $138,500.00 |
DisclosureSEC source: 0001127602-17-000737 · form4.xml · nonDerivative · entry 3 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,957 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:26 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 250 | $14.13 | $3,532.50 |
DisclosureSEC source: 0001127602-17-000737 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,457 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 22:26 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,250 | $15.95 | $35,887.50 |
DisclosureSEC source: 0001127602-17-000737 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 4,768 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · derivative · entry 10 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,768 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
SaleOrdinary Shares | 4,768 | $57.73 | $275,265.22 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · nonDerivative · entry 6 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,587 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.50 to $57.91. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 16, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 4,768 | $16.55 | $78,910.40 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · nonDerivative · entry 5 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,355 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 00:00 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001127602-16-070167 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Underlying: Ordinary Shares · 5,000 shares Expires 2021-05-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 00:00 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 5,000 | $55.99 | $279,963.00 |
DisclosureSEC source: 0001127602-16-070167 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,640 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.81 to $56.22. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 15, 2016 Filed Dec 16, 2016 00:00 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 5,000 | $18.11 | $90,525.00 |
DisclosureSEC source: 0001127602-16-070167 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 16,690 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · derivative · entry 9 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,768 Underlying: Ordinary Shares · 16,690 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
SaleOrdinary Shares | 16,690 | $57.62 | $961,719.53 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · nonDerivative · entry 4 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,587 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $57.50 to $57.77. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 15, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 16,690 | $16.55 | $276,219.50 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · nonDerivative · entry 3 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,277 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 23:54 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $11.74 | $0.00 |
DisclosureSEC source: 0001127602-16-070166 · form4.xml · derivative · entry 10 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,983 Underlying: Ordinary Shares · 10,000 shares Expires 2020-05-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 23:54 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 15,000 | $0.00 Strike: $14.13 | $0.00 |
DisclosureSEC source: 0001127602-16-070166 · form4.xml · derivative · entry 9 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2017-11-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F7 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 23:54 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
SaleOrdinary Shares | 100 | $55.20 | $5,520.00 |
DisclosureSEC source: 0001127602-16-070166 · form4.xml · nonDerivative · entry 4 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,342 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 23:54 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
SaleOrdinary Shares | 24,900 | $54.72 | $1,362,612.66 |
DisclosureSEC source: 0001127602-16-070166 · form4.xml · nonDerivative · entry 3 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,442 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.20 to $55.19. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 23:54 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionOrdinary Shares | 10,000 | $11.74 | $117,400.00 |
DisclosureSEC source: 0001127602-16-070166 · form4.xml · nonDerivative · entry 2 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 137,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 14, 2016 Filed Dec 15, 2016 23:54 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
Exercise / conversionOrdinary Shares | 15,000 | $14.13 | $211,950.00 |
DisclosureSEC source: 0001127602-16-070166 · form4.xml · nonDerivative · entry 1 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,342 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| December 14, 2016 Filed Dec 19, 2016 22:06 UTC |
Pugh Gordon GSVP, COO & CRO, Alkermes, Inc.
|
GiftOrdinary Shares | 7,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-070469 · form4.xml · nonDerivative · entry 2 Pugh Gordon G · CIK 0001376545 · SVP, COO & CRO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Indirect · Gordon G. Pugh Revocable Trust - 2012 Disclosed balance after: 38,737 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.